Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure

Herz

Volumn 35, Issue 7, 2010, Pages 488-496

  Luers C ^a   Schmidt, A ^b   Wachter, R ^c   Fritzsche, F ^c   Sutcliffe, A ^c   Kleta, S ^c   Zapf, A ^d   Hagenah, G ^e   Binder, L ^c   Maisch, B ^a   Pieske, B ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e Nephrologisches Zentrum Göttingen GbR   (Germany)

Author keywords

Decompensated heart failure; Heart failure; Natriuretic peptides; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; AGED; AORTA VALVE STENOSIS; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; FEMALE; GERMANY; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 78649329479     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-010-3377-4     Document Type: Article

References (31)

1. Ho KK, Anderson KM, Kannel WB et al (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88(1):107-115
2. Heeschen C, Hamm CW, Mitrovic V et al (2004) N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110(20):3206-3212
3. Katayama T, Nakashima H, Takagi C et al (2005) Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock. Circ J 69(1):83-88 (Pubitemid 40139614)
4. White HD, Palmeri ST, Sleeper LA et al (2004) Electrocardiographic findings in cardiogenic shock, risk prediction and the effects of emergency revascularization: results from the SHOCK trial. Am Heart J 148(5):810-817
5. Jarai R, Fellner B, Haoula D et al (2009) Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels. Crit Care Med 37(6):1837-1844
6. Meyer B, Huelsmann M, Wexberg P et al (2007) N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 35(10):2268-2273
7. Roch A (2007) What does high NT-proBNP mean in septic shock patients? A part of the puzzle. Crit Care 11(2):122
8. Maisel AS, Krishnaswamy P, Nowak RM et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347(3):161-167
9. Mueller C, Scholer A, Laule-Kilian K et al (2004) Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350(7):647-654 (Pubitemid 38364623)
10. Bettencourt P, Ferreira A, Dias P et al (2000) Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology 93(1-2):19-25
11. Hobbs FD, Davis RC, Roalfe AK et al (2002) Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 324(7352):1498
12. Kwan G, Isakson SR, Beede J et al (2007) Short-term serial sampling of natriuretic peptides in patients presenting with chest pain. J Am Coll Cardiol 49(11):1186-1192
13. Talwar S, Squire IB, Downie PF et al (2000) Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J 21(18):1514-1521
14. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29(19):2388-2442
15. Remme WJ, Swedberg K (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22(17):1527-1560 (Pubitemid 32801300)
16. Richards AM, Doughty R, Nicholls MG et al (2001) Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol 37(7):1781-1787
17. Troughton RW, Frampton CM, Yandle TG et al (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355(9210):1126-1130
18. Cheitlin MD, Armstrong WF, Aurigemma GP et al (2003) ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 16(10):1091-1110
19. Quinones MA, Otto CM, Stoddard M et al (2002) Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15(2):167-184
20. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32-35
21. Lemos JA de, Morrow DA, Bentley JH et al (2001) The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345(14):1014-1021
22. Maeder MT, Ammann P, Rickli H et al (2008) N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea. Sleep Breath 12(1):7-16
23. Maeder MT, Wolber T, Ammann P et al (2008) Cardiopulmonary exercise testing in mild heart failure: impact of the mode of exercise on established prognostic predictors. Cardiology 110(2):135-141
24. Bettencourt P, Azevedo A, Pimenta J et al (2004) N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110(15):2168-2174
25. Bibbins-Domingo K, Ansari M, Schiller NB et al (2003) B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 108(24):2987-2992
26. Omland T, Lemos JA de, Morrow DA et al (2002) Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 89(4):463-465 (Pubitemid 34142525)
27. Jernberg T, Stridsberg M, Venge P et al (2002) N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 40(3):437-445
28. Kotanidou A, Karsaliakos P, Tzanela M et al (2009) Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population. Shock 31(4):342-347
29. Fonarow GC, Peacock WF, Phillips CO et al (2007) Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49(19):1943-1950
30. Gill D, Seidler T, Troughton RW et al (2004) Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction. Clin Sci (Lond) 106(2):135-139
31. Kazanegra R, Cheng V, Garcia A et al (2001) A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7(1):21-29 (Pubitemid 32285185)